The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Tuesday, March 11, 2008
P133

Time from Treatment to Re-infection with Chlamydia trachomatis or Neisseria gonorrhoeae in Patients with and without Co-infection

Juanita M. Brand, Coya Campbell, Virginia A. Caine, and Barbara Van Der Pol. Bell Flower Clinic, Marion County Health Department, 3838 N. Rural Street, Indianapolis, IN, USA


Background:
C.trachomatis (CT) and N.gonorrhoeae (GC) infections are increasing in many populations in the U.S. despite active STI control efforts. Data from Canadian public health efforts suggest a significant proportion of CT infections are re-infections in the same individuals. Understanding factors that may increase risk of re-infection is critical to development of effective control strategies.

Objective:
To describe rates of CT and GC re-infection in clients co-infected compared to those with single infections.

Method:
Data from June 2005 were used to identify a cohort of individuals infected with CT and/or GC reported from STD*MIS database in Central Indiana. Kaplan-Meier estimates of time to re-infection were compared for those with & without co-infection (á=.05).

Result:
627 & 303 clients were diagnosed with CT &/or GC, respectively. 114 clients were infected with both organisms (CT-18.1% & GC- 37.6%). Mean time to re-infection for
CT-clients originally co-infected or CT only: 241 days(± 47.1) and 302 days (± 19.3). Mean time to re-infection for
GC-clients originally co-infected or GC only: 285 days
(± 51.9) and 273 days (± 32.8). Of the 513 and 189 persons infected with CT or GC only, 65 (12.7%) and 27 (14.3%) were re-infected within 1 year. Of the 114 co-infected, 13 (11.4%) were re-infected within 1 year. These differences were not statistically significant. Cox regression analysis with covariants did not reveal additional significant factors.

Conclusion:
Infection with both CT and GC is common: >1/3 of those with GC also have CT. However, co-infection w/CT & GC does not appear to decrease time to re-infection in this cohort.

Implications:
Although understanding re-infection is critical to care & management of STIs, analysis of co-infection does not appear to provide clinicians with additional information regarding future risk. Further analysis of an expanded cohort related to infections beyond first re-infection will be performed to verify findings.